GNLX insider filings

GENELUX Corp — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-05. Screen GNLX transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 6 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Zindrick Thomas — President and CEO2—2 legs · 37,552 sh · $98,216—
Cappello Joseph — Chief Technical Officer2—2 legs · 10,925 sh · $29,475—
Yu Yong — Chief Scientific Officer2—2 legs · 10,351 sh · $28,002—

Recent insider filings — GENELUX Corp

FiledFormInsiderReported transactionsSource
2026-11-054Yu Yong — Chief Scientific OfficerSale (S): 668 @ $2.01EDGAR
2026-11-054Zindrick Thomas — President and CEOSale (S): 3,089 @ $2.05EDGAR
2026-11-054Cappello Joseph — Chief Technical OfficerSale (S): 668 @ $2.04EDGAR
2026-09-024Yu Yong — Chief Scientific OfficerSale (S): 9,683 @ $2.75EDGAR
2026-09-024Zindrick Thomas — President and CEOSale (S): 34,463 @ $2.67EDGAR
2026-09-024Cappello Joseph — Chief Technical OfficerSale (S): 10,257 @ $2.74EDGAR
2026-08-044Zindrick Thomas — President and CEOSale (S): 3,023 @ $2.95EDGAR
2026-08-044Cappello Joseph — Chief Technical OfficerSale (S): 653 @ $2.95EDGAR
2026-08-044Yu Yong — Chief Scientific OfficerSale (S): 653 @ $2.94EDGAR
2026-07-024Smither John W — DirectorSale (S): 12,000 @ $2.91EDGAR
2026-06-184Pulisic Matthew — Chief Financial OfficerGrant/award (A): 278,906 @ $0EDGAR
2026-06-184Groen Eric — General CounselGrant/award (A): 233,957 @ $0EDGAR
2026-06-184Cappello Joseph — Chief Technical OfficerGrant/award (A): 174,841 @ $0EDGAR
2026-06-184Tyree James L — DirectorGrant/award (A): 28,409 @ $0 · Grant/award (A): 31,566 (derivative) @ $0EDGAR
2026-06-184Zindrick Thomas — President and CEOGrant/award (A): 730,601 @ $0EDGAR
2026-06-184Thomas John — DirectorGrant/award (A): 28,409 @ $0 · Grant/award (A): 31,566 (derivative) @ $0EDGAR
2026-06-184Mirabelli Mary — DirectorGrant/award (A): 28,409 @ $0 · Grant/award (A): 31,566 (derivative) @ $0EDGAR
2026-06-184Yu Yong — Chief Scientific OfficerGrant/award (A): 119,318 @ $0EDGAR
2026-06-184Smither John W — DirectorGrant/award (A): 28,409 @ $0 · Grant/award (A): 31,566 (derivative) @ $0EDGAR
2026-06-044Smalling Ralph — Head of RegulatorySale (S): 192 @ $2.93EDGAR
2026-06-024Thomas John — DirectorSale (S): 10,000 @ $2.98EDGAR
2026-05-124Cappello Joseph — Chief Technical OfficerSale (S): 605 @ $2.97EDGAR
2026-05-124Yu Yong — Chief Scientific OfficerSale (S): 605 @ $2.97EDGAR
2026-05-124Zindrick Thomas — President and CEOSale (S): 2,798 @ $2.94EDGAR
2026-05-124Smalling Ralph — Head of RegulatorySale (S): 270 @ $2.98EDGAR
2026-03-264Smalling Ralph — Head of RegulatorySale (S): 345 @ $2.42 · Sale (S): 240 @ $2.51EDGAR
2026-03-264Cappello Joseph — Chief Technical OfficerSale (S): 906 @ $2.42EDGAR
2026-03-264Yu Yong — SVP, Clinical DevelopmentSale (S): 906 @ $2.42EDGAR
2026-03-264Zindrick Thomas — President and CEOSale (S): 3,582 @ $2.42EDGAR
2026-03-034Thomas John — DirectorSale (S): 10,000 @ $2.90EDGAR
2026-01-074Litten Jason — Chief Medical OfficerGrant/award (A): 275,000 (derivative) @ $0EDGAR
2025-12-114Zindrick Thomas — President and CEOSale (S): 12,673 @ $3.33 · Sale (S): 4,509 @ $5.37EDGAR
2025-12-114Yu Yong — SVP, Clinical DevelopmentSale (S): 3,219 @ $3.36 · Sale (S): 973 @ $5.37EDGAR
2025-12-114Cappello Joseph — Chief Technical OfficerSale (S): 1,270 @ $3.33 · Sale (S): 1,463 @ $3.36 · Sale (S): 973 @ $5.37EDGAR
2025-12-094Smalling Ralph — Head of RegulatorySale (S): 1,244 @ $3.36 · Sale (S): 580 @ $3.36 · Sale (S): 343 @ $5.37 · Sale (S): 165 @ $4.69EDGAR
2025-12-024Thomas John — DirectorSale (S): 10,000 @ $5.00EDGAR
2025-09-034Zindrick Thomas — President and CEO, DirectorDisposition to issuer (D): 925,000 (derivative) · Grant/award (A): 925,000 (derivative) · Disposition to issuer (D): 157,372 (derivative) · Grant/award (A): 157,372 (derivative) · Disposition to issuer (D): 23,568 (derivative) · Grant/award (A): 23,568 (derivative) · +2 moreEDGAR
2025-09-034Yu Yong — SVP, Clinical DevelopmentDisposition to issuer (D): 207,652 (derivative) · Grant/award (A): 207,652 (derivative) · Disposition to issuer (D): 65,000 (derivative) · Grant/award (A): 65,000 (derivative)EDGAR
2025-09-034Smalling Ralph — Head of RegulatoryGrant/award (A): 10,000 @ $0 · Disposition to issuer (D): 8,333 (derivative) · Grant/award (A): 8,333 (derivative)EDGAR
2025-09-034Cappello Joseph — Chief Technical OfficerDisposition to issuer (D): 16,666 (derivative) · Grant/award (A): 16,666 (derivative) · Disposition to issuer (D): 80,000 (derivative) · Grant/award (A): 80,000 (derivative) · Disposition to issuer (D): 13,333 (derivative) · Grant/award (A): 13,333 (derivative) · +2 moreEDGAR
2025-08-294Tyree James L — DirectorGrant/award (A): 22,283 @ $0 · Grant/award (A): 28,576 (derivative) @ $0EDGAR
2025-08-294Smither John W — DirectorGrant/award (A): 22,283 @ $0 · Grant/award (A): 28,576 (derivative) @ $0EDGAR
2025-08-294Mirabelli Mary — DirectorGrant/award (A): 22,283 @ $0 · Grant/award (A): 28,576 (derivative) @ $0EDGAR
2025-08-294Thomas John — DirectorGrant/award (A): 22,283 @ $0 · Grant/award (A): 28,576 (derivative) @ $0EDGAR
2025-08-294Zindrick Thomas — President and CEOGrant/award (A): 361,200 @ $0 · Grant/award (A): 478,800 (derivative) @ $0EDGAR
2025-08-294Yu Yong — SVP, Clinical DevelopmentGrant/award (A): 101,480 @ $0 · Grant/award (A): 134,520 (derivative) @ $0EDGAR
2025-08-294Smalling Ralph — Head of RegulatoryGrant/award (A): 26,230 @ $0 · Grant/award (A): 34,770 (derivative) @ $0EDGAR
2025-08-294Cappello Joseph — Chief Technical OfficerGrant/award (A): 107,500 @ $0 · Grant/award (A): 142,500 (derivative) @ $0EDGAR
2025-07-024Groen Eric — General Counsel & SecretaryGrant/award (A): 270,000 (derivative) @ $0EDGAR
2025-06-244Thomas John — DirectorGift (G): 25,000 @ $0EDGAR

Recent 8-K events — GENELUX Corp

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-06-228-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-03-198-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2026-02-028-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-088-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-058-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-028-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2025-09-038-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.07 — Submission of Matters to a Vote of Security Holders
EDGAR
2025-03-258-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2025-03-258-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2025-02-038-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=GNLX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs